-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Lapatinib is a targeted therapy drug used in the treatment of breast cancer and ovarian cancer.
The production process of lapatinib involves several steps, from the preparation of raw materials to the final product.
In this article, we will discuss the production process of lapatinib in detail.
- Raw Material Preparation:
The production of lapatinib involves several raw materials, including 2,4-diamino-6-ethoxy-m-xylene, 3-(4,4-difluoro-2-oxo-1,3-oxazolidin-3-yl)-4-methoxy- phenylamine, and several other chemical compounds.
These raw materials are procured from reliable suppliers and are stored in a proper storage facility until they are needed for production.
- Synthesis of 2,4-diamino-6-ethoxy-m-xylene:
2,4-diamino-6-ethoxy-m-xylene is synthesized using several chemical reactions, including nitration, bromination, and diazotization.
The reaction is carried out under controlled conditions to ensure the purity of the final product.
The synthesized 2,4-diamino-6-ethoxy-m-xylene is then used in the next step of the production process.
- Synthesis of 3-(4,4-difluoro-2-oxo-1,3-oxazolidin-3-yl)-4-methoxy-phenylamine:
3-(4,4-difluoro-2-oxo-1,3-oxazolidin-3-yl)-4-methoxy-phenylamine is synthesized by several chemical reactions, including alkylation, halogenation, and oxidation.
The reaction is carried out in several steps and is monitored to ensure that the reaction is proceeding as expected.
The final product is then collected and used in the next step of the production process.
- Reaction of 2,4-diamino-6-ethoxy-m-xylene and 3-(4,4-difluoro-2-oxo-1,3-oxazolidin-3-yl)-4-methoxy-phenylamine:
2,4-diamino-6-ethoxy-m-xylene and 3-(4,4-difluoro-2-oxo-1,3-oxazolidin-3-yl)-4-methoxy-phenylamine are combined in a reaction vessel under controlled conditions.
The reaction is catalyzed by a Lewis acid catalyst, such as tantalum ethoxide.
The reaction is monitored to ensure that it is proceeding as expected, and the final product is collected and purified.
- Purification of Lapatinib:
The final product of the reaction is a mixture of several isomers, which are then separated and purified using several techniques, including high-performance liquid chromatography (HPLC) and recrystallization.
The purified lapatinib is then dried and packaged in appropriate containers for storage and shipment.
- Quality Control:
Before the final product is released for sale, it undergoes several quality control tests, including physical tests, chemical tests, and microbiological tests.
The results of these tests are recorded and used to ensure that the final product meets the required standards for quality and safety.
In conclusion, the production process of lapatinib involves several steps, from the preparation of raw materials to the final product.
The process requires careful control and monitoring to ensure that the final product meets the required standards for quality and safety.
With proper quality control, lapatinib can be an effective treatment option for breast and ovarian cancer patients.